305 related articles for article (PubMed ID: 11273362)
1. Clinical resistance to ciprofloxacin in Salmonella typhi.
Rodrigues C; Mehta A; Andrews R; Joshi VR
J Assoc Physicians India; 1998 Mar; 46(3):323-4. PubMed ID: 11273362
[No Abstract] [Full Text] [Related]
2. Enteric fever treatment failures: a global concern.
Chandel DS; Chaudhry R
Emerg Infect Dis; 2001; 7(4):762-3. PubMed ID: 11585550
[No Abstract] [Full Text] [Related]
3. A clinical comparison of typhoid fever caused by susceptible and multidrug-resistant strains of Salmonella typhi.
Alsoub H; Uwaydah AK; Matar I; Zebeib M; Elhag KM
Br J Clin Pract; 1997; 51(1):8-10. PubMed ID: 9158264
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
Prabha Adhikari MR; Baliga S
J Assoc Physicians India; 2002 Mar; 50():428-9. PubMed ID: 11924574
[No Abstract] [Full Text] [Related]
5. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
[TBL] [Abstract][Full Text] [Related]
6. A case of ciprofloxacin-resistant typhoid fever.
Umasankar S; Wall RA; Berger J
Commun Dis Rep CDR Rev; 1992 Nov; 2(12):R139-40. PubMed ID: 1284936
[No Abstract] [Full Text] [Related]
7. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
Ciraj AM; Seema DS; Bhat GK; Shivananda PG
Indian J Pathol Microbiol; 2001 Oct; 44(4):407-8. PubMed ID: 12035350
[No Abstract] [Full Text] [Related]
8. Multidrug-resistant Salmonella typhi in India.
Chitnis V; Chitnis D; Verma S; Hemvani N
Lancet; 1999 Aug; 354(9177):514-5. PubMed ID: 10465202
[No Abstract] [Full Text] [Related]
9. Ciprofloxacin in the management of multiple drug resistant typhoid fever.
Sen S; Goyal RS; Dev R
Indian Pediatr; 1991 Apr; 28(4):417-9. PubMed ID: 1752663
[No Abstract] [Full Text] [Related]
10. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Gupta LK; Randhawa VS
Indian J Med Microbiol; 2008; 26(4):406. PubMed ID: 18974511
[No Abstract] [Full Text] [Related]
11. [What does it mean 'sensitive'? Failing ciprofloxacin in typhus abdominalis].
van 't Wout JW; Jones JO; Visser LG; Bijlmer HA; Veldkamp PJ; van Dissel JT
Ned Tijdschr Geneeskd; 2009 May; 153(19):914-8. PubMed ID: 19489296
[No Abstract] [Full Text] [Related]
12. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
Gupta V; Kaur J
Int J Infect Dis; 2008 Nov; 12(6):e143-4. PubMed ID: 18514007
[No Abstract] [Full Text] [Related]
13. Ciprofloxacin-resistant Salmonella typhi in the UK.
Rowe B; Ward LR; Threlfall EJ
Lancet; 1995 Nov; 346(8985):1302. PubMed ID: 7475749
[No Abstract] [Full Text] [Related]
14. Multi-resistant typhoid fever.
Bhattacharya SK; Dutta D; Bhattacharya MK; Rasaily R; Dutta P; Saha A; Saha MR; Pal SC
Natl Med J India; 1992; 5(1):41. PubMed ID: 1304255
[No Abstract] [Full Text] [Related]
15. Treatment of enteric fever--what next?
Misra S; Thapa BR; Panigrahi D; Mehta S
Indian Pediatr; 1991 Apr; 28(4):433-5. PubMed ID: 1752667
[No Abstract] [Full Text] [Related]
16. Typhoid fever: narrowing therapeutic options in India.
Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
[TBL] [Abstract][Full Text] [Related]
17. [A case with fever of unknown origin during treatment for malaria: multi-drug resistant Salmonella typhi infection].
Akin K; Yavuzdemir S; Cesur S; Levent B; Esen B; Willke A
Mikrobiyol Bul; 2005 Jan; 39(1):83-7. PubMed ID: 15900841
[TBL] [Abstract][Full Text] [Related]
18. Low-level quinolone-resistance in multi-drug resistant typhoid.
Mirza SH; Khan MA
J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
[TBL] [Abstract][Full Text] [Related]
19. Emerging drug resistance and vaccination for typhoid fever.
Atkins BL; Gottlieb T
JAMA; 1998 Feb; 279(8):579; author reply 580. PubMed ID: 9486743
[No Abstract] [Full Text] [Related]
20. Ciprofloxacin breakpoints in enteric fever: time to revise our susceptibility criteria.
Rodrigues C; Kumar NJ; Lalwani J; Mehta A
Indian J Med Microbiol; 2009; 27(3):276. PubMed ID: 19584518
[No Abstract] [Full Text] [Related]
[Next] [New Search]
